• Delivers premium visual quality at all distances
    • First and only FDA-approved accommodating IOL
    • Mimics natural focusing action of the eye
    • Provides single focal point
    • Mimics natural accommodative arching

  • Delivers long-term stability
    • Patients showed better vision quality seven years after surgery than they did at one year post-op1

  • Delivers 100% of available light rays at all distances, so patients can see near, intermediate, and far subjects without compromise

  • Is easy to adopt for your practice
    • Certification is quick and easy; hands-on customer support is always nearby
Dr. Devgan Quote

References
1. Seven-year follow-up data from original AT-45 clinical trial data.
2. Data on file.

Visit www.crystalens.com for more information on cataract surgery.